Frost & Sullivan’s report, “Smart Prevention—Health Care Cost Savings Resulting From the Targeted Use of Dietary Supplements,” commissioned through a grant from the Council for Responsible Nutrition Foundation (CRNF), has found that the use of B vitamins in adults over the age of 55 with Coronary Heart Disease (CHD) could potentially reduce the number of hospitalizations related to this disease. As a result of supplemental vitamin B consumption, the report suggests that significant savings could be made in individual and societal health care costs.
 
Some scientific research has demonstrated that B vitamins—B6, folic acid and B12—may have a positive role in heart health. The B vitamins help maintain healthy homocysteine levels, which, when elevated, are a risk factor for hardening of the arteries and blood clot formation.
 
The economic report showed that preventive intake levels of B vitamins, costing only 11 cents per day, are an inexpensive way for adults over the age of 55 with CHD to help reduce the risk of an expensive hospitalization related to their CHD. A cumulative 808,225 CHD-related medical events from 2013 to 2020 could be avoided if the targeted population took B vitamins at preventive intake levels, the report found.
 
To achieve the report findings, Frost & Sullivan conducted a systematic review of scientific research in peer-reviewed, published studies that looked at a relationship between B vitamin intake and the risk of a CHD-attributed event. The firm then projected the rates of CHD-attributed medical events across U.S. adults over the age of 55 with CHD and applied a cost benefit analysis to determine the cost savings if people in this targeted population took B vitamins at preventive intake levels.